C. Blout

发表

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.

Matthew S. Lebo, Heidi L Rehm, Danielle R Azzariti, 2017, Annals of internal medicine.

Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium

Marian J. Gilmore, B. Bernhardt, J. Wynn, 2018, Journal of Genetic Counseling.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Nikhil Wagle, Peter Tarczy-Hornoch, Richard M Myers, 2016, American journal of human genetics.

Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network

John A. Lynch, David C. Kochan, Marc S. Williams, 2020, Journal of personalized medicine.

Newborn Screening: Education, Consent, and the Residual Blood Spot. The Position of the National Society of Genetic Counselors

C. Blout, M. Fox, C. Walsh Vockley, 2014, Journal of Genetic Counseling.

Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011))

Sara Chandros Hull, Robert C. Green, Sean D. Mooney, 2016 .

The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial.

Matthew S. Lebo, Danielle R Azzariti, D. Bates, 2017, Annals of internal medicine.

Informed consent for exome sequencing research in families with genetic disease: The emerging issue of incidental findings

A. Telegrafi, K. Raraigh, C. Blout, 2014, American journal of medical genetics. Part A.

THE ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN INTRONIC REGIONS OF ISLET CELL AUTOANTIGEN 1 AND TYPE 1 DIABETES MELLITUS

C. Blout, 2006 .

Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.

Robert C. Green, Keith Marsolo, Casey Overby Taylor, 2019, American journal of human genetics.

Short Term Costs of Integrating Whole Genome Sequencing into Primary Care and Cardiology Settings: A Pilot Randomized Trial

Robert C. Green, Natasha K. Stout, Heidi L. Rehm, 2018, Genetics in Medicine.

A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients

Matthew S. Lebo, R. Green, H. Rehm, 2017, Circulation. Cardiovascular genetics.

3 Cirino at al Comparing Panel and Whole Genome Sequencing in HCM Results Patient Characteristics

Matthew S. Lebo, R. Green, H. Rehm, 2017 .

Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy.

A. Moser, D. Valle, K. Doheny, 2014, American journal of human genetics.

Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network

Marc S. Williams, W. Chung, R. Green, 2020, Journal of personalized medicine.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2018, Genetics in Medicine.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2019, Genetics in Medicine.

Airmen and Healthcare Providers’ attitudes toward the use of genomic sequencing in the US Air Force: Findings from the MilSeq Project

Matthew S. Lebo, Cubby L. Gardner, R. Green, 2020, Genetics in Medicine.

Short Term Costs of Integrating Whole Genome Sequencing into Primary Care and Cardiology Settings: A Pilot Randomized Trial

Danielle R Azzariti, Christine Y. Lu, R. Green, 2018, Genetics in Medicine.

A whole genome approach for discovering the genetic basis of blood group antigens: independent confirmation for P1 and Xga

Matthew S. Lebo, R. Green, W. Lane, 2018, Transfusion.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Matthew S. Lebo, Victoria A. Miller, Jeffrey W. Pennington, 2016, American journal of human genetics.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, H. Rehm, K. Goddard, 2019, Genetics in Medicine.

Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes

Matthew J. Thomas, J. Rosenfeld, B. Torchia, 2012, European Journal of Human Genetics.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Joseph S. Salama, W. Chung, I. Krantz, 2016, American journal of human genetics.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

N. Spinner, K. Goddard, L. Hindorff, 2018, Genetics in Medicine.